Benhealth Biopharmaceutical (Shenzhen) Co., Ltd.

Quick facts

Phase 2 pipeline

• Activated CIK · Oncology
  Activated CIK (cytokine-induced killer cells) are ex vivo expanded immune cells that target and kill cancer cells through multiple mechanisms including natural killer and T-cell pathways.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Benhealth Biopharmaceutical (Shenzhen) Co., Ltd. portfolio CI brief
• Benhealth Biopharmaceutical (Shenzhen) Co., Ltd. pipeline updates RSS

Related

• Sector hub: All tracked pharma companies